Cargando...

Evaluation of the Biodistribution of Serinolamide-Derivatized C(60) Fullerene

Carbon nanoparticles have consistently been of great interest in medicine. However, there are currently no clinical materials based on carbon nanoparticles, due to inconsistent biodistribution and excretion data. In this work, we have synthesized a novel C(60) derivative with a metal chelating agent...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nanomaterials (Basel)
Main Authors: Zaibaq, Nicholas G., Pollard, Alyssa C., Collins, Michael J., Pisaneschi, Federica, Pagel, Mark D., Wilson, Lon J.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7023239/
https://ncbi.nlm.nih.gov/pubmed/31941058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nano10010143
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!